TrialEuropean urology2015

Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator.

Donna P Ankerst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.